相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Sverker Hasselblom et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
The emerging mechanisms of isoform-specific PI3K signalling
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
Krishna M. Vasudevan et al.
CANCER CELL (2009)
PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
Lakshmi Srinivasan et al.
CELL (2009)
Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells
Uta Ferch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A20 Negatively Regulates T Cell Receptor Signaling to NF-κB by Cleaving Malt1 Ubiquitin Chains
Michael Duewel et al.
JOURNAL OF IMMUNOLOGY (2009)
The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-κB and activate T cells
Sung-Gyoo Park et al.
NATURE IMMUNOLOGY (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
Stephan Hailfinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma
Lloyd T. Lam et al.
BLOOD (2008)
T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20
Beatrice Coornaert et al.
NATURE IMMUNOLOGY (2008)
The proteolytic activity of the paracaspase MALT1 is key in T cell activation
Fabien Rebeaud et al.
NATURE IMMUNOLOGY (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival
Shahab Uddin et al.
BLOOD (2006)
Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110α inhibitors
Masahiko Hayakawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
A loss-of-function RNA interference screen for molecular targets in cancer
VN Ngo et al.
NATURE (2006)
Two-step cross-linking method for identification of NF-κB gene network by chromatin immunoprecipitation
DE Nowak et al.
BIOTECHNIQUES (2005)
Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1
RI Feldman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The IKK/NF-κB activation pathway -: a target for prevention and treatment of cancer
FR Greten et al.
CANCER LETTERS (2004)
Src-family kinases in B-cell development and signaling
SB Gauld et al.
ONCOGENE (2004)
Phosphoinositide 3-kinase: Diverse roles in immune cell activation
JA Deane et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction
H Suzuki et al.
NATURE IMMUNOLOGY (2003)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
分享论文
